Skip to main content

Table 2 Multivariable Cox regression of systemic recurrence-free survival and breast cancer–specific survival in operable breast cancer patients (n = 191) according to pre-operative DTC status after median 15.3 years of follow-up

From: Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients

Parameter

Hazard ratio

95% CI

p-value

Systemic recurrence-free survival

Pre-operative DTC status (pos. vs neg.)

2.94

1.385–6.339

0.006

Post-operative DTC status (pos. vs neg.)

2.87

1.335–6.184

0.007

MAI status (high vs low)

2.65

1.352–5.186

0.005

Breast cancer–specific survival

Pre-operative DTC status (pos. vs neg.)

3.48

1.389–8.723

0.008

Post-operative DTC status (pos. vs neg.)

2.67

1.033–6.885

0.043

MAI status (high vs low.)

4.35

1.916–9.874

< 0.001

  1. Only results from backward stepwise selection of variables are presented. Results from overall survival are not presented.
  2. p-value ≤0.05 are in bold